Recent fermentation studies have identified actinomycetes of the marine-dwelling genus Salinispora as prolific natural product producers. To further evaluate their biosynthetic potential, we analyzed all identifiable secondary natural product gene clusters from the recently sequenced 5,184,724 bp S. tropica CNB-440 circular genome. Our analysis shows that biosynthetic potential meets or exceeds that shown by previous Streptomyces genome sequences as well as other natural product-producing actinomycetes. The S. tropica genome features nine polyketide synthase systems of every known formally classified family, non-ribosomal peptide synthetases and several hybrid clusters. While a few clusters appear to encode molecules previously identified in Streptomyces species, the majority of the 15 biosynthetic loci are novel. Specific chemical information about putative and observed natural product molecules is presented and discussed. In addition, our bioinformatic analysis was critical for the structure elucidation of the novel polyene macrolactam salinilactam A. This study demonstrates the potential for genomic analysis to complement and strengthen traditional natural product isolation studies and firmly establishes the genus Salinispora as a rich source of novel drug-like molecules.
Introduction
Actinomycetes are an exceptionally prolific source of secondary metabolites accounting for more than half of all microbial antibiotics discovered to date (1). Remarkably, the vast majority of these compounds are derived from the single actinomycete genus Streptomyces, raising the intriguing possibility that additional, chemically prolific taxa await discovery. Further incentive to explore actinomycetes as a source of novel secondary metabolites comes from the genome sequences of S. coelicolor (2) and S. avermitilis (3) , both of which revealed many unanticipated biosynthetic gene clusters thus demonstrating that even well-studied taxa have the potential to yield new metabolites. Such genomic-based information has been used not only to predict the chemical structures of previously unobserved metabolites but also to develop fermentation methods that enhance their production (4-7). Bioinformatics-based approaches to natural product discovery have also been used successfully at the industrial level, where genome scanning has led to the discovery of significant new chemical entities (8, 9) . These methods have great potential to eliminate the redundant isolation of previously described compounds while allowing detailed fermentation studies or molecular cloning experiments to be focused on strains that possess a high probability of producing new chemical structures.
Genomics has already been particularly useful to microbial natural products studies because actinomycete secondary metabolites such as polyketides, nonribosomal peptides, and hybrids thereof are often biosynthesized by large, multifunctional synthases that in an assembly line process sequentially assemble small carboxylic acid and amino acid building blocks into their products (10) . The biosynthetic genes responsible for the production of these metabolites are almost invariably tightly packaged into operon-like clusters that include regulatory elements and resistance mechanisms (2) . In the case of modular polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) systems, the repetitive domain structures associated with these megasynthases generally follow a co-linearity rule (11) which, when combined with bioinformatics and biosynthetic precedence, can be used to predict the chemical structures of new polyketide and peptide-based metabolites.
Marine-derived actinomycetes have become a focus in the search for novel secondary metabolites (12) . Among the strains cultured from marine samples is the genus Salinispora, which was recently described as the first seawater-requiring marine actinomycete (13) . This genus is widely distributed in tropical and subtropical ocean sediments and is currently comprised of the two formally described species, S. tropica and S. arenicola, and a third species for which the name S. pacifica has been proposed (14) . These actinomycetes are proving to be an exceptionally rich source of structurally diverse secondary metabolites, which are produced in species-specific patterns (15) . In the case of S. tropica, the compounds observed to date from this bacterium include the potent proteasome inhibitor salinosporamide A (16), which is currently in phase I human clinical trials for the treatment of cancer, the unprecedented halogenated macrolides sporolides A and B (17), lymphostin, which was observed by scientists at Nereus Pharmaceuticals during salinosporamide A fermentation development (R. Lam, personal communication) and was first reported from a Streptomyces species (18) and, salinilactam, the structure of which was solved as part of the present study.
Here we report all identified secondary metabobolic biosynthetic gene clusters deriving from the complete genome sequence of the marine actinomycete S. tropica strain CNB-440. This strain is now found to hold the most diverse assemblage of polyketide biosynthetic mechanisms observed in a single organism, as well as the largest percentage of a genome devoted to natural product biosynthesis to date. Bioinformatic analysis was used to facilitate the structure elucidation of the novel polyene macrolactam salinilactam A. Sequence analyses further revealed that many of these clusters are likely to have been introduced into this genome as a result of recent horizontal gene transfer, which has important implications to origin of this organism's secondary metabolome.
Results and Discussion
General features of the genome and associated secondary metabolome. The complete genome sequence of S. tropica strain CNB-440 revealed a single circular chromosome comprising 5,184,724 bp, with no plasmids, and an average G+C content of 69.5% (Fig. 1) This analysis revealed 15 secondary metabolic biosynthesis gene clusters that we predict to be involved in siderophore, melanin, polyketide, non-ribosomal peptide, and aminocyclitol production ( Table 1 ). The combined length of these gene clusters is estimated at 492 kb, establishing that, amongst sequenced bacteria to date, S. tropica devotes the largest percentage of its genome (~9.5%) to natural product assembly (Table 1) . These analyses also confirm that the biosynthetic potential of this strain is considerably greater than that observed by fermentation, as was previously reported in analyses of the S. coelicolor and S. avermitilis genome sequences (2, 3) .
Two thirds of the clusters are concentrated in a single quadrant of the chromosome nearly antipodal to the replication-controlling dnaA gene (Fig. 1) . This section of the genome also harbors A striking feature of the S. tropica genome is its remarkable diversity of polyketide biosynthetic pathways, which is greater in variety than in other sequenced bacterial genomes (Table   1 ). Pathways include those for modular type I PKSs (slm), iterative enediyne type I PKSs (spo and pks1), hybrid type I PKS-NRPSs (sal, sid2, sid3, and lym), heterodimeric type II PKSs (pks2 and pks3), and a homodimeric type III PKS (pks4) (Fig. 1) . Interestingly, none of the type I PKSassociated modules, of which there are 15, contain a full set of reductive domains required to completely reduce the transient β-carbonyl group to a saturated methylene carbon during the polyketide elongation process. Hence, S. tropica PKS-derived products are expected to be highly oxidized, as is the case for the characterized metabolites salinosporamide A (sal), sporolide A (spo), lymphostin (lym), and salinilactam A (slm) (Fig. 2) .
A primary motivation for the sequencing of the CNB-440 strain of S. tropica was that it is a producer of the potent anticancer agent salinosporamide A (16) . Its biosynthetic gene cluster (sal) encodes a 29-ORF, 41-kb unprecedented hybrid PKS-NRPS pathway (Fig. 2E ) involving new mechanisms in chlorination and β-lactone synthesis as well as 20S proteasome resistance (23) . In addition to the sal cluster, S. tropica harbors two additional hybrid PKS-NRPS pathways. The lym cluster is proposed to synthesize the lymphocyte kinase inhibitor lymphostin, which was first isolated from Streptomyces sp. KY11783 (18) . We propose that the uniquely organized twomodule synthase LymA catalyzes a single polyketide extension followed by reductive offloading and N-acetylation of a non-proteinogenic tricyclic planar amino acid derived from tryptophan, with subsequent O-methylation catalyzed by an adjacent SAM-dependent methyl transferase LymB (Fig. 2F) . A set of four genes with homology to a domain of unknown function (DUF611) may play a role in the synthesis of the tryptophan-derived primer unit. The sid2 cluster bears strong domain organization (though lacks direct sequence similarity) to the yersiniabactin cluster (ybt) from Yersinia pestis (24) and other organisms (Fig. 2B) . Although no siderophore molecules have yet been isolated from Salinispora species, the notable similarity in domain structure very strongly suggests that the resulting molecule will have the yersiniabactin polyketide/non-ribosomal peptide core with possible alterations in sites of methylation and/or oxidation.
Two independent, novel enediyne PKS biosynthetic gene clusters (spo and pks1) are found in the S. tropica genome. Enediyne natural products, such as the potent DNA cleaving agents calicheamicin, dynemicin, C-1027, and neocarzinostatin are polyketide secondary metabolites produced by members of the order Actinomycetales, many of which (like the genus Salinispora) belong to the family Micromonosporaceae (25) . The enediyne polyketide structural motif falls into two classes that possess either 9-or 10-membered rings, and their associated PKSs are phylogenetically distinct. Phylogenetic analysis of the S. tropica enediyne PKSs associated with the spo and pks1 clusters revealed that they are putatively involved in the biosynthesis of distinct 9-and 10-membered enediyne polyketides, respectively (Fig. 3) . While no enediyne natural products have yet been directly characterized from S. tropica, sporolides A and B (17) are putatively derived from a 9-membered enediyne PKS product that is uniquely halogenated with chloride during the aromatization of the enediyne unit to yield the tricyclic hydrocarbon nucleus (26) . The ~71-kb spo cluster harbors as many as 53 ORFs, which include other conserved enediyne PKS-associated genes, as well as those encoding the postulated biosynthesis and coupling of the sporolide cyclohexenone unit deriving from the amino acid tyrosine. The 10-membered enediyne PKS in gene cluster pks1 also bears the canonical enediyne PKS domain architecture, and further analysis of its 30-kb gene cluster did not reveal accessory genes involved in deoxyhexose biosynthesis and attachment, nor additional polyketide pathways typically associated with 10-membered enediyne polyketide biosynthesis (i.e., calicheamicin and dynemicin), suggesting that this orphan pathway codes for the biosynthesis of a novel natural product.
In addition to the abundance of diverse PKS pathways, S. tropica harbors four NRPS operons (nrps1, nrps2, sid3, and sid4) (Fig. 1) . While the products of the dimodular nrps1 and novel tetramodular nrps2 gene clusters are unknown and could not be accurately predicted on the basis of bioinformatics alone (27, 28) , sid3 and sid4 are homologous to gene sets encoding known siderophore pathway biosynthetic enzymes. When combined with the highly homologous S.
coelicolor NRPS-independent siderophore desferrioxamine (29) cluster sid1 ( Fig. 2A) and the ybt homologous PKS-NRPS hybrid cluster sid2 (Fig. 2B) , a total of four identifiable siderophore-like clusters reside in S. tropica. The three assembly line siderophore synthetases encoded by gene sets sid2-4 each have related priming mechanisms involving homologous ATP-dependent aryl-CoA ligases, which typically incorporate aromatic residues such as salicylate or 2,3-dihydroxybenzoate into their NRP siderophore products such as yersiniabactin, enterobactin, and pyochelin (30) . The sid4 gene cluster has strongest homology with a biosynthetic cluster for an as-yet unisolated siderophore ('coelibactin') from S. coelicolor (Fig. 2D) (2) . The S. tropica sequence, however, differs from that in S. coelicolor in that it is flanked by an additional transport system typical of siderophore export and iron-bound uptake. The smaller sid3 cluster is adjacent to the sid4 cluster and encodes a highly unusual type II PKS and a single NRPS module that we propose to extend and cyclize an aromatic acid with cysteine, tentatively producing a siderophore-like intermediate (Fig. 2C) . It is unclear if sid3 is fully functional or is instead biosynthetically linked with sid4.
While the latter three gene clusters are traditionally found in γ-proteobacteria, these S. tropica gene clusters bear %G+C values similar to the S. tropica total genome percentage, and therefore do not suggest a very recent assimilation, despite similarities to existing clusters.
Genome-guided natural product discovery of salinilactam A. The slm cluster is the largest S. tropica biosynthetic cluster and consists of six genes encoding a ten-module PKS with 49 domains. Due to the highly repetitive nature of the DNA sequence associated with the slm loci and an extremely high level of sequence identity (>99% in many regions), assembly of the cluster and, as a consequence, closure of the genome was problematic. Initial inspection of the partial slm gene cluster from an early draft genome sequence suggested that it coded for a novel lysine-primed polyene macrolactam polyketide devoid of sugar or other appendages often associated with polyketide natural products. A fermentation broth of S. tropica CNB-440 was inspected for new compounds with characteristic UV chromophores associated with polyene units, which led to the isolation of a series of new polyene macrolactams exemplified by salinilactam A (Fig. 2G ). NMR and MS characterization of salinilactam A quickly revealed a novel polyene macrolactam framework, which was only consistent with the slm cluster. Structural features included two isolated polyene fragments, a 1,2,3,5-tetrahydroxy alkane moiety, three methyl groups, and an amide functionality. However, completion of the structure was initially hindered due to the instability of the compound and the presence of eight conjugated olefins with similar NMR properties.
Inspection of the structure fragments, together with the molecular formula C 2 8 H 3 9 NO 5 revealed by high-resolution mass spectrometry, suggested that salinilactam A was derived from a PKS with at least ten extension modules. This information was useful to help resolve and properly assemble the repetitive DNA sequences associated with slm into two operons (slmABCD and slmNO) separated by nine accessory genes presumed to be involved in starter unit biosynthesis and macrolactam hydroxylation (Fig. 2G) . On the basis of the co-linearity rule of modular polyketide biosynthesis, the relationship of slm to the terminal region of the vicenistatin PKS (31) , and partial NMR-based structural fragments, we were able to accurately predict the gross chemical structure of salinilactam A. The natural product would thus be produced by chain extension of the novel lysinederived PKS starter unit 5-aminohex-2-enoate with eight malonate and two methylmalonate units followed by macrolactamization and cytochome P450 hydroxylation at C-8.
The salinilactam A structure was verified by comprehensive NMR analyses on the purified natural product to confirm the bioinformatics-based structure assignment. Although the relative and absolute stereochemistry of salinilactam A was not determined spectroscopically, the stereochemistry of the C-7, C-9, and C-11 hydroxyl groups was predicted to be R, S, and R, respectively, based upon strong homology of all slm ketoreductase (KR) domains to other "Atype" KRs (32) . The intimate interplay between microbial genomics, biosynthetic logic and natural product chemistry was critical not only in the structure elucidation of this new chemical entity, but also in the final closure of the genome sequence.
Conclusions
There is an ongoing resurgence in natural product drug discovery research (33) . This renewed interest is driven by the inherent structural diversity and biological activity associated with secondary metabolites, the low productivity of alternative drug discovery strategies, and the application of improved analytical methods that make it possible to solve structures using small quantities of material. A relatively new concept that can be added to this list is the molecular genetics of natural product biosynthesis (34) . Advances in this field, in combination with increased access to DNA sequencing, are providing a wealth of information about how natural products are assembled, mechanisms by which natural product gene clusters can be manipulated to yield new product diversity, and the genetic potential of individual organisms. Concerning the later, complete genome sequencing provides unparalleled access to the genes involved in secondary metabolism, how they are assembled, and in some cases, what products they may yield. Armed with these data, it becomes possible to compare the compounds observed using traditional fermentation procedures with those that are predicted from gene sequences, design fermentation methods that may activate or enhance the production of predicted products, and assess the evolutionary history of individual gene clusters. The genus Salinispora has become a model organism to address questions about speciesspecific patterns of natural product production (15) and, as described in the present study, the application of whole genome sequencing to the process of natural product discovery and structure elucidation.
Genome sequencing of S. tropica has revealed an abundance of novel biosynthetic gene clusters, the majority of which were unexpected based on previous fermentation analyses of this and closely related species and strains. With this information now available, there is a clear need for further genome-guided fermentation studies as our analysis clearly confirms the value of the Salinispora genus as a source of novel drug-like molecules. In the absence of other Micromonsporacea genome sequences, it is unclear if this natural product diversity is general to this family or if the diversity in the genus Salinispora derives from environmental novelty.
Sequencing of a related species, Salinispora arenicola CNS-205, already underway, should shed further light on the metabolic capabilities of this newly described marine actinomycete genus.
Outside of the exploratory aspects of this project, our bioinformatic analysis was of broad practical utility in conjunction with natural product isolation. The isolation of a large polyene molecule led to identification and resolution of a large, repetitive PKS sequence, the analysis of which spurred further refinement and identification of salinilactam A as a novel polyene. With the genome information in hand we expect that it will facilitate similar studies in the future, and this result demonstrates the benefits that can result from greater interplay between information technology and natural product structure elucidation. We recently developed a genetics system in S. tropica for rapid gene knockouts via PCR targeting that will further facilitate the genome mining of this metabolically rich bacterium (23) .
Currently, the implications for secondary metabolism due to the circular nature of the S. tropica chromosome are unclear. A mechanism for the biogenesis of novel secondary metabolic clusters in linear chromosomes was recently reported (35) , and makes clear that the instability found at of the terminal ends of Streptomyces linear chromosomes has been utilized to provide rapid evolutionary adaptability to the organism. By contrast, no particular region of the circular S. tropica chromosome seems unstable to the same degree observed in the chromosomal ends of Streptomyces as pseudogenes are largely absent and secondary metabolic clusters and transposable elements are more dispersed throughout the chromosome. This may indicate that Salinispora species will have more frequently acquired their secondary metabolic systems horizontally from other species rather than evolving most themselves. It will be appealing to put this hypothesis to the test when the S. arenicola CNS-205 genome is completed and directly compared to S. tropica CNB-440.
Materials and Methods
Genome sequencing, annotation and analysis. Draft sequencing and automated annotation was provided by the Department of Energy, Joint Genome Institute (JGI) under the Community Sequencing Program and has been deposited with GenBank (AATJ00000000). Automated gene prediction and functional annotation was performed by the Genome Analysis Pipeline (36) .
Automated prediction of protein-coding genes was based on the output of CRITICA (37) complemented with the output of Glimmer (38) . Initial functional annotation was performed using To more specifically identify and categorize natural product biosynthetic gene clusters, a custom Perl script was written to sequentially search each translated protein sequence via BLASTP alignment against a hand-constructed and expandable library of model natural product domains and genes. Hits were grouped by physical proximity within the chromosome, and putative clusters were further examined using software available at the NCBI website and visualized with Vector NTI (Invitrogen). Transposons and other mobile genetic element ORFs were identified in a similar manner. Annotations of all gene clusters discussed were deposited with GenBank (for accession numbers, see Table 2 ). 
